Healthcare & Medical Devices Global On demand · 24-48h

Global Peripheral IV Catheter (PIVC) Market Strategic Research Report

Global Peripheral IV Catheter (PIVC) Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Peripheral IV Catheter (PIVC) Market
$5.62B2025
5.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Conventional Type, Safety Type

By Application: Hospital, Clinic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BD, B. Braun, ICU Medical, Cook, Teleflex Incorporated, Terumo, NIPRO, Linhwa Medical, Shanghai KDL, Jiangxi Sanxin, Shandong Weigao, Medikit, Ander Medical, Tuoren Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 123 pages
Market size 2025
$5.62B
Billion USD
Forecast CAGR
5.8%
2025-2032
Forecast 2032
$8.3B
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Peripheral IV Catheter (PIVC) market size is predicted to grow from US$ 5,616 million in 2025 to US$ 8,272 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

Peripheral Intravenous Catheter (PIVC) is a fundamental clinical infusion device designed to establish a venous access point through peripheral veins, enabling rapid and safe administration of medications, nutrients, and blood products. Typically composed of a cannula, introducer needle, safety mechanisms, and locking components, PIVCs are widely used in surgical anesthesia, emergency care, long-term infusion, and antibiotic therapy. With the global healthcare industry’s increasing emphasis on safety and quality standards, PIVCs are evolving with innovations in safety features, closed-system compatibility, and patient comfort, gradually replacing traditional needles. As a high-frequency, indispensable consumable, PIVCs are used not only in general hospitals and primary care institutions but are also expanding into home healthcare and telemedicine, making them a key growth segment within the medical device market.In 2024, global Peripheral Intravenous Catheter production reached approximately 2,345 million units, with an average global market price of around US$ 2.2 per unit.

The PIVC market is driven by global population aging, rising chronic disease prevalence, and increasing healthcare expenditure. Strengthened regulations on medical safety standards worldwide are accelerating the adoption of safety and closed-system catheters, shifting the market from low-cost consumables toward high-value devices. Continuous investment in R&D and supply chain infrastructure by multinational corporations and leading domestic players, combined with centralized procurement in public hospitals and rising demand for premium products internationally, provides significant growth potential. Furthermore, digital healthcare and smart infusion systems are fostering integration opportunities, enhancing market competitiveness.

The sector faces risks from raw material price volatility, stricter regulatory compliance, and price pressures due to centralized purchasing programs. Established global brands hold strong market positions, posing challenges for emerging companies in expanding internationally. Uneven adoption of safety catheters in some regions and diversified regulatory frameworks also contribute to market uncertainties, alongside geopolitical trade tensions.

Demand diversification is evident as PIVCs see growing use beyond hospital-based infusion, notably in chronic disease management, home care, and mobile health services. As premium healthcare and precision nursing become more widespread, users prioritize comfort, dwell time, and insertion success rates, driving innovation in needle safety, closed systems, and biocompatible materials. Favorable reimbursement policies and rising surgical volumes further support market expansion.

PIVCs primarily utilize high-performance medical-grade polymers such as polyurethane (PU) and polytetrafluoroethylene (PTFE), with needles manufactured from precision stainless steel. The upstream sector is relatively concentrated, with prices influenced by global oil and chemical supply chains. Leading companies are vertically integrating material R&D and manufacturing to mitigate cost volatility while advancing high-end product differentiation. Environmental regulations are also encouraging the adoption of eco-friendly materials and recyclable product lines.

This report presents a comprehensive overview of the global Peripheral IV Catheter (PIVC) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Conventional Type
  • Safety Type

Segment by Injection

  • Non-Power Injection
  • Power Injection

Segment by Application

  • Hospital
  • Clinic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Peripheral IV Catheter (PIVC) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Peripheral IV Catheter (PIVC) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$5.62B
2025
Forecast
$8.3B
2032
CAGR
5.8%
2025–2032
Gebieden
5
global
Key companies
BDB. BraunICU MedicalCookTeleflex IncorporatedTerumoNIPROLinhwa Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Conventional TypeSafety Type
By Application
HospitalClinicOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Conventional Type
  • 3.1.3 Safety Type
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 B. Braun
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 ICU Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Cook
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Teleflex Incorporated
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Terumo
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 NIPRO
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Linhwa Medical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Shanghai KDL
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Jiangxi Sanxin
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shandong Weigao
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Medikit
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Ander Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Tuoren Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Peripheral IV Catheter (PIVC) market?
The global Peripheral IV Catheter (PIVC) market is estimated at US$ 5.62 billion in 2025 (base year) and is projected to reach US$ 8.27 billion by 2032.
How fast is the Peripheral IV Catheter (PIVC) market expected to grow?
The market is expected to grow at a CAGR of 5.8% from 2026 to 2032, expanding from US$ 5.62 billion in 2025 to US$ 8.27 billion in 2032, roughly 1.5 times its base-year value.
What does the Peripheral IV Catheter (PIVC) market cover?
Peripheral Intravenous Catheter (PIVC) is a fundamental clinical infusion device designed to establish a venous access point through peripheral veins, enabling rapid and safe administration of medications, nutrients, and blood products. Typically composed of a cannula, introducer needle, safety mechanisms, and locking components, PIVCs are widely used in surgical anesthesia, emergency care, long-term infusion, and antibiotic therapy.
What are the main segments of the Peripheral IV Catheter (PIVC) market by type?
By type, the market is segmented into Conventional Type and Safety Type.
Which applications drive demand in the Peripheral IV Catheter (PIVC) market?
Key applications covered include Hospital, Clinic and Other.
Who are the key players in the Peripheral IV Catheter (PIVC) market?
Key players profiled include BD, B. Braun, ICU Medical, Cook, Teleflex Incorporated, Terumo, NIPRO and Linhwa Medical, among 14 companies covered in total.
Which regions and countries are covered for Peripheral IV Catheter (PIVC)?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Peripheral IV Catheter (PIVC) market?
The PIVC market is driven by global population aging, rising chronic disease prevalence, and increasing healthcare expenditure.
What challenges does the Peripheral IV Catheter (PIVC) market face?
The sector faces risks from raw material price volatility, stricter regulatory compliance, and price pressures due to centralized purchasing programs.
Who should buy the Peripheral IV Catheter (PIVC) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Peripheral IV Catheter (PIVC) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.